Janet B McGill

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Diabetes technology & therapeutics

The Journal of clinical endocrinology and metabolism

Diabetes, obesity & metabolism

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Washington University in Saint Louis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Washington University in Saint Louis Jul 01 1987

United States

Professor of Medicine :: Medicine

Publications

Hetal S Shah, Janet B McGill, Irl B Hirsch, Chunyi Wu, Andrzej Galecki, Ian H de Boer, Michael Mauer, Alessandro Doria
Poor Glycemic Control Is Associated With More Rapid Kidney Function Decline After the Onset of Diabetic Kidney Disease. The Journal of clinical endocrinology and metabolism 109 (8) (2024)
Schafer C Boeder, Michael J Davies, Janet B McGill, Richard Pratley, Manon Girard, Phillip Banks, Jeremy Pettus, Satish Garg
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin. Diabetes technology & therapeutics (2024)
Hetal S Shah, Janet B McGill, Irl B Hirsch, Chunyi Wu, Andrzej Galecki, Ian H de Boer, Michael Mauer, Alessandro Doria
Poor glycemic control is associated with more rapid kidney function decline after the onset of diabetic kidney disease. The Journal of clinical endocrinology and metabolism (2024)
Schafer C Boeder, Michael J Davies, Janet B McGill, Richard Pratley, Manon Girard, Phillip Banks, Jeremy Pettus, Satish Garg
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin. Diabetes technology & therapeutics (2024)
Hetal S Shah, Janet B McGill, Irl B Hirsch, Chunyi Wu, Andrzej Galecki, Ian H de Boer, Michael Mauer, Alessandro Doria
Poor Glycemic Control Is Associated With More Rapid Kidney Function Decline After the Onset of Diabetic Kidney Disease. The Journal of clinical endocrinology and metabolism 109 (8) (2024)
Schafer C Boeder, Michael J Davies, Janet B McGill, Richard Pratley, Manon Girard, Phillip Banks, Jeremy Pettus, Satish Garg
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin. Diabetes technology & therapeutics 26 (9) (2024)
David S H Bell, Janet B McGill, Terri Jerkins
Management of the 'wicked' combination of heart failure and chronic kidney disease in the patient with diabetes. Diabetes, obesity & metabolism (2023)
Gregory P Forlenza, Anders L Carlson, Rodolfo J Galindo, Davida F Kruger, Carol J Levy, Janet B McGill, Guillermo Umpierrez, Grazia Aleppo
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations. Diabetes technology & therapeutics 24 (11) (2022)
Rodolfo J Galindo, Christopher G Parkin, Grazia Aleppo, Anders L Carlson, Davida F Kruger, Carol J Levy, Guillermo E Umpierrez, Janet B McGill
What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring. Diabetes technology & therapeutics 23 (9) (2021)
Max C Petersen, Jonah M Graves, Tony Yao, Lutz Schomburg, Waldemar B Minich, Deborah L Parks, Janet B McGill, Maamoun Salam
Insulin Receptor Autoantibody-mediated Hypoglycemia in a Woman With Mixed Connective Tissue Disease. Journal of the Endocrine Society 6 (1) (2021)
Grazia Aleppo, Christopher G Parkin, Anders L Carlson, Rodolfo J Galindo, Davida F Kruger, Carol J Levy, Guillermo E Umpierrez, Gregory P Forlenza, Janet B McGill
Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion. Diabetes technology & therapeutics 23 (10) (2021)
Rong M Zhang, Ritika Puri, Janet B McGill
Update on Biosimilar Insulins: A US Perspective. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (4) (2021)
Janet B McGill, Mariko Johnson, Stacy Hurst, William T Cade, Kevin E Yarasheski, Richard E Ostlund, Kenneth B Schechtman, Babak Razani, Michael B Kastan, Donald A McClain, Lisa de Las Fuentes, Victor G Davila-Roman, Daniel S Ory, Samuel A Wickline, Clay F Semenkovich
Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness. Diabetology & metabolic syndrome 11 (2019)

Janet B McGill.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Janet B McGill